Category: Interventional Cardiology
New Cardiac Monitor Uses Nanogenerators Powered by Human Body
Researchers at Purdue University have been developing a wearable cardiac monitor that functions by harvesting the energy of the human body. The device uses TENG’s, triboelectric nanogenerators, with... Read More
Abiomed Impella Granted Emergency Use Authorization to Treat COVID-19 Cardiac Symptoms
The FDA has granted Emergency Use Authorization to Abiomed for their left-sided Impella heart pumps. These pumps are used to support patients during heart failure and provide left ventricular unloadin... Read More
Boston Scientific Granted FDA Approval for Stroke Prevention Device
According to iData’s latest Interventional Cardiology market report, Boston Scientific is the leading competitor in this market. Now, they have produced another innovative interventional cardiol... Read More
Medtronic receives CE mark for Micra AV Pacemaker
Medtronic has received a CE mark for its Micra AV Pacemaker, the world’s smallest pacemaker with atrioventricular (AV) synchrony. This device is used to treat AV block, a condition marked by impaire... Read More
FDA Grants Emergency Use Authorization to Abiomed for Impella RP
Abiomed has been granted FDA emergency use authorization for its Impella RP – a temporary heart pump to support circulatory system functioning in patients with right side ventricular failure. The FD... Read More
Terumo Aortic Gains FDA Breakthrough Status for Aortic Repair Device
Terumo Aortic, a company that focuses exclusively on producing devices regarding aorta, has developed the Thoraflex Hybrid to aid patients who have suffered from a thoracic aortic aneurysm, or a tear ... Read More
World’s First Transcatheter Mitral Valve Approved in Europe
World’s First Transcatheter Mitral Valve Approved in Europe Abbott‘s Tendyne system is the world’s first transcatheter mitral valve replacement (TMVR) technology to receive commercia... Read More
Vascular Graft Solutions Acquires Patent Property by Kips Bay Medical Inc.
Vascular Graft Solutions (VGS), an Israeli-based interventional cardiology company that specalizes in improving the outcomes of coronary and peripheral bypass surgeries, has announced the acquisition ... Read More
